Thursday, November 12, 2026

USD/EUR Rises By 1% In The Last 21 Sessions

USD/EUR Rises By 1% In The Last 21 Sessions

(VIANEWS) - USD/EUR (USDEUR) has been up by 1.54% for the last 21 sessions. At 03:06 EST on Thursday, 2 March, USD/EUR (USDEUR) is $0.94.

USD/EUR's yearly highs and lows, it's 5.178% up from its 52-week low and 10.275% down from its 52-week high.

Volatility

USD/EUR's last week, last month's, and last quarter's current intraday variation average was 0.26%, 0.23%, and 0.43%, respectively.

USD/EUR's highest amplitude of average volatility was 0.26% (last week), 0.47% (last month), and 0.43% (last quarter), respectively.

News about

  • Eur/usd to climb back towards 1.10 by the end of March – socgen. According to FXStreet on Tuesday, 28 February, "We argued that a bit of risk aversion and wider credit spreads could take EUR/USD to 1.06 (and GBP/USD below 1.2). ", "Both went marginally further, and we could still see some wobbles in the days ahead but yield differentials should start to matter again and I expect we'll be climbing back towards EUR/USD 1.10 by the end of March."
  • Eur/usd: inflation data might support the euro this week – commerzbank. According to FXStreet on Tuesday, 28 February, "For the time being, however, the USD side should be able to stand its ground so that scope for higher EUR/USD levels should be limited at present."
  • Eur/usd remains firm and climbs to 3-day highs near 1.0620. According to FXStreet on Tuesday, 28 February, "The single currency extends the auspicious start of the week and lifts EUR/USD to the 1.0620 region, or 3-session tops, on turnaround Tuesday.", "Price action around EUR/USD remains somewhat flat in line with the rest of the global markets, although the pair manages well to reclaim the area beyond 1.0600 the figure so far on Tuesday."
  • According to FXStreet on Tuesday, 28 February, "The Euro remains little impressed by the above comments, as EUR/USD loses 0.19% on the day to trade at 1.0585 at the time of writing."

More news about USD/EUR (USDEUR).

ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Biotech Catalyst Wave: Late-2026 Clinical Readouts, PDUFA Dates and Capital Restructuring
A dense cluster of Q4 2026 to Q1 2027 clinical and regulatory catalysts spans hepatitis delta (Vir's ECLIPSE/SOLSTICE), hypertension and sleep apnea (Mineralys' lorundrostat, PDUFA 2026-12-22), severe hypertriglyceridemia (plozasiran), oncology (ivonescimab BLA, PDUFA 2026-11-14) and gene therapy (Krystal). Positive data flow from AASLD and AHA presentations is offset by cost-cutting guidance, milestones slipping into 2027, and a delisting process that signals capital-market stress for some issuers. Near-term value hinges on binary FDA decisions and Phase 3 topline readouts in Q1 2027.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,995
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,995 facts checked against source5,565 source documents archived
Query this data → isubstrate.com